DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 01 · Volume 55 · January 2022 DOI: 10.1055/s-012-52719 Special Issue Psychotropic Drugs and COVID

Editorial

  • 5
    Bauer, Michael; Juckel, Georg:

    Covid-19: Contributions from Psychopharmacology

    • Review

  • 7
    Mueller, Juliane K.; Riederer, Peter; Müller, Walter E.:

    Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?

  • 16
    Khosravi, Mohsen:

    Candidate Psychotropics against SARS – CoV – 2: A Narrative Review

  • 24
    Nykamp, Madeline J.; Zorumski, Charles F.; Reiersen, Angela M.; Nicol, Ginger E.; Cirrito, John; Lenze, Eric J.:

    Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease Prevention

    Supplementary Material (PDF)
  • 48
    Veerman, Selene R. T.; Bogers, Jan P. A. M.; Cohen, Dan; Schulte, Peter F. J.:

    COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine

    • Original Paper

  • 30
    Bonnet, Udo; Claus, BenediktBernd; Schaefer, Martin; Kuhn, Jens; Nyhuis, Peter; Scherbaum, Norbert; Brüne, Martin; Wakili, Velat; Juckel, Georg:

    Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-area

  • 40
    Plasencia-García, Beatriz Oda; Rico-Rangel, María Isabel; Rodríguez-Menéndez, Gonzalo; Rubio-García, Ana; Torelló-Iserte, Jaime; Crespo-Facorro, Benedicto:

    Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases

    Supplementary Material (PDF)

    • Letter to the Editor

  • 57
    Papadopoulos, Konstantinos I.; Sutheesophon, Warachaya; Aw, Tar-Choon:

    Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase

  • 58
    Khosravi, Mohsen:

    A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection